Organization | CEDRA Clinical Research

CEDRA Clinical Research Report issue

For profit Phase 1

Founded: Austin TX United States (1984)

Status: Acquired by Worldwide Clinical Trials (2010)

Organization Overview

First Clinical Trial

2003

NCT00602173

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2010

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CEDRA | Cedra Clinical Research, LLC. | CEDRA Clinical Research, LLC,

Active Ingredients

Drugs in Phase 1 Trials (13)

baclofen (lioresal) (1 trial)

buprenorphine (2 trials)

codeine (Phenergan) (5 trials)

doxycycline (vibramycin) (2 trials)

fentanyl (Innovar) (1 trial)

levetiracetam (keppra) (2 trials)

morphine (7 trials)

mycophenolate (CellCept) (6 trials)

naltrexone (revia) (1 trial)

phenserine (1 trial)

ramipril (altace) (5 trials)

sertraline (zoloft) (2 trials)

valproic acid (depakene) (2 trials)

Drugs in Other Trials (5)

cilostazol (pletal) (2 trials)

hydrochlorothiazide (esidrix) (2 trials)

losartan (cozaar) (2 trials)

pilocarpine (ocusert) (4 trials)

zidovudine (retrovir) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alcoholism (Phase 1)

Alzheimer Disease (Phase 1)

Cognitive Dysfunction (Phase 1)

Disease (Phase 1)

Malnutrition (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 46
# of Trial APIs: 18